What type of study is this?

This is a Experimental Study study.

Hydatid cyst derived molecules potentiate the protective effect of sulfasalazine in murine induced colitis: Role of FOXP3 T-regulatory cells in colonic tissues

View Full Paper

Ask AI

Bookmark

Authors

Combined treatment with hydatid cyst fluid and sulfasalazine improved disease metrics in a murine colitis model, highlighting cytokine modulation.

Significant improvement in disease metrics was observed in mice treated with sulfasalazine and hydatid cyst extracts.
Combination therapy elevated Foxp3+ T-reg cell expression while reducing inflammatory cytokines like TNF-α.
The study employed acetic acid-induced colitis in mice to measure the therapeutic effects of hydatid cyst-derived compounds.
Findings suggest hydatid cyst molecules could offer novel therapeutic strategies for colitis and other inflammatory conditions.

Darwish et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Combined treatment with hydatid cyst fluid and sulfasalazine improved disease metrics in a murine colitis model, highlighting cytokine modulation.